Abbisko Therapeutics Co. Ltd.
- Biotech or pharma, therapeutic R&D
Abbisko Therapeutics (Stock Code: 02256. HK) is dedicated to discover and develop novel and differentiated therapies in oncology and beyond to address critical unmet medical needs for patients in China and worldwide. The company was established in Shanghai by a group of seasoned drug hunters with rich R&D and managerial expertise from top multinational pharmaceutical companies. Since its founding in 2016, Abbisko Therapeutics has built up an extensive pipeline of 18 innovative small molecule programs focused on precision oncology and immuno-oncology, including 12 clinical stage assets.
We will not accept meeting request from CRO, CDMO or any other service vendor, thanks!
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}